Genitourinary Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

By Product (Urologicals, Hormonal Therapy, Gynecological, Anti-infectives, Others), By Indication (Prostate cancer, Ovarian cancer, Bladder cancer, Cervical cancer, Renal cancer, Erectile dysfunction, Urinary tract infections, Urinary incontinence & overactive bladder, Sexually transmitted diseases, Interstitial cystitis, Hematuria, Benign prostatic hyperplasia), By Drug Type (Hormonal Therapy, Impotence Agents, Urinary Antispasmodics, Urinary pH Modifiers, Uterine Relaxants, Uterine Stimulants), By Region, and Competition

Published	Pages	Publisher	Report code
Nov 2023	181	TechSci Research	ASDR-640724

Published: Nov 2023 - Pages : 181 - Publisher : TechSci Research - Report code : ASDR-640724

1. Abbott Laboratories Inc
2. Bristol-Myers Squibb Co
3. Novartis AG
4. Genentech Inc
5. F Hoffmann-La Roche AG
6. Ionis Pharmaceuticals Inc
7. Eli Lilly & Co
8. Merck & Co Inc
9. Pfizer Inc
10. AstraZeneca PLC

Acute Care Syndromic Testing - Global Forecast 2024-2030

This report can be of interest as well:

Acute Care Syndromic Testing - Global Forecast 2024-2030

Published: January, 2024 | Report code: ASDR-653807